Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$413,755,406
+$9,965,339 QoQ
Shares Held
344,960
-21.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#176
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. LLY ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $413,755,406 | 344,960 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $403,790,067 | 439,012 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $466,139,268 | 433,747 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $238,093,387 | 312,049 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $238,371,698 | 305,789 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $222,895,764 | 269,879 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $211,172,108 | 273,539 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $238,733,365 | 269,469 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $218,200,200 | 241,004 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $190,823,474 | 245,287 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $129,408,822 | 222,001 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $112,557,739 | 209,554 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $87,044,562 | 185,604 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $63,814,990 | 185,822 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $77,258,822 | 211,182 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $70,255,224 | 217,273 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $68,572,050 | 211,492 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $48,310,332 | 168,699 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $46,081,229 | 166,828 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $34,165,362 | 147,870 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $30,162,141 | 131,414 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $13,167,820 | 70,484 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $15,803,423 | 93,600 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $13,223,218 | 89,334 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $16,947,480 | 103,225 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $20,415,005 | 147,167 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||